AKT1 and osteosarcoma: These findings are very important guidelines for our in-depth understanding and study of chemotherapeutic drug resistance in microRNA/PI3K/AKT pathway osteosarcoma cells, and we can target these microRNAs to find possible solutions to the resistance of osteosarcoma cells to pharmacotherapeutic drugs.